sec filing
NM
NASDAQ · NMRA
Neumora Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$1.31
Down-$0.04 (-2.96%)
Updated Sep 7, 2026, 4:29 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 346.56M
- P/E ratio
- -1.42
- Dividend yield
- 0.00%
- 52-week range
- $0.83 – $3.52
- Volume
- 549.21K
- Avg. volume
- 1.61M
Price performance
NMRA price history
1M range · 20 trading sessions · Daily adjusted prices
NMRA closed at $1.31 after 20 trading sessions, down 19.14% for the selected period.
- Last close
- $1.31
- Period change
- -19.14%
- Period low
- $1.31
- Period high
- $1.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $1.35 | $1.36 | $1.29 | $1.31 | 549.21K |
| Sep 3, 2026 | $1.39 | $1.39 | $1.34 | $1.35 | 386.04K |
| Sep 2, 2026 | $1.35 | $1.41 | $1.345 | $1.38 | 532.23K |
| Sep 1, 2026 | $1.33 | $1.36 | $1.31 | $1.33 | 532.62K |
| Aug 31, 2026 | $1.40 | $1.445 | $1.32 | $1.33 | 633.1K |
| Aug 28, 2026 | $1.50 | $1.51 | $1.38 | $1.39 | 696.29K |
| Aug 27, 2026 | $1.55 | $1.575 | $1.48 | $1.48 | 534.04K |
| Aug 26, 2026 | $1.50 | $1.57 | $1.46 | $1.56 | 536.19K |
| Aug 25, 2026 | $1.53 | $1.57 | $1.48 | $1.50 | 475.57K |
| Aug 24, 2026 | $1.58 | $1.65 | $1.51 | $1.525 | 1.16M |
| Aug 21, 2026 | $1.51 | $1.64 | $1.51 | $1.63 | 499.11K |
| Aug 20, 2026 | $1.61 | $1.63 | $1.475 | $1.515 | 1.49M |
| Aug 19, 2026 | $1.65 | $1.71 | $1.615 | $1.64 | 716.17K |
| Aug 18, 2026 | $1.50 | $1.65 | $1.48 | $1.64 | 781.77K |
| Aug 17, 2026 | $1.55 | $1.585 | $1.46 | $1.52 | 1.35M |
| Aug 14, 2026 | $1.69 | $1.71 | $1.58 | $1.60 | 1.17M |
| Aug 13, 2026 | $1.71 | $1.785 | $1.675 | $1.73 | 488.29K |
| Aug 12, 2026 | $1.70 | $1.76 | $1.675 | $1.71 | 351.61K |
| Aug 11, 2026 | $1.62 | $1.70 | $1.61 | $1.70 | 517.5K |
| Aug 10, 2026 | $1.65 | $1.66 | $1.57 | $1.62 | 580.79K |
Latest NMRA news
The latest Smart Investors Daily articles mentioning NMRA.
Stock researchResearch & News · SEC Filings
Loading stock research…